ANI Pharma (ANIP) Approves $25M Common Stock Buyback Plan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
ANI Pharmaceuticals Announces Board Authorization of Stock Repurchase Program
October 5, 2015 8:00 AM EDTBAUDETTE, Minn., Oct. 5, 2015 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP)  announced today that its Board of Directors has authorized a stock repurchase program under which the Company may repurchase up to $25 million of shares of the Company's common stock. ANI expects to fund the stock repurchase program through cash on hand. Â
The authorization allows for repurchases to be conducted through open market or through privately negotiated transactions through December 31, 2016. The number of shares repurchased and the timing of repurchases will depend on a number of factors, including, but not... More
